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Abstract 
MicroRNAs (miRNAs) are a class of small, ~22-nt-long endogenous, single-stranded 
non-coding RNAs (ncRNAs) that takes part in post-transcriptional gene silencing through 
deadenylation, translational repression, and destroying their target messenger RNAs (mRNAs)  
They exert their regulatory role on the corresponding mRNAs by binding to their 3’UTR, CDS 
and 5’UTR. When SNP occurs in 3’ UTRs, it changes the mRNA stability and translation by 
altering the miRNA::mRNA interactions. SNPs present in the 3’UTR of genes associated with 
breast cancer might contribute to the initiation and susceptibility of the malignancy. In this work, 
we aim to find the significant pairs of target SNP:miRNA by using the different in silico 
methods. From our analysis, we screened and got six potential target SNP pairs which have been 
proposed to be involved in breast cancer risk in females.  
 
Key word:  miRNA, SNP, UTR, CDS, mRNA, non-coding RNA. 
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Introduction: 
Cancer is a class of deadly disease characterized by uncontrolled cell growth. More than 200 
different types of cancer have been identified till now. Each cancer is classified on the basis of 
type of cell that is initially affected. When growth of the damaged cell is uncontrolled, it forms 
lump or masses of tissue, known as tumors. Tumor cells release certain chemicals (cytokines, 
hormones) that alter normal function of the body. A benign tumor like skin wart is always 
present in its original location and do not invade or spread to the surrounding tissues. A 
malignant tumor, however invades and spread to the surrounding tissues through the circulatory 
system and lymphatic system. These malignant tumors are known as cancer. 
Cancer possesses several biological capabilities that are acquired during the development 
of human tumors. These hallmarks basically constitute an organizing principle for rationalizing 
the complexities of the cancer. These are tissue invasion, genetic instability, tumor promoting 
inflammation, sustained growth signaling, evading anti-growth signaling, resisting programmed 
cell death, enables repilcative immortality, deregulated cellular metabolism, avoiding immune 
destruction, inducing new blood flow (Hanahan and Weinberg, 2011).  
 
                                                 Figure 1: Hallmarks of cancer. 
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 Major causes of cancer are different lifestyle, genetic disorder, carcinogens, virus, and 
bacterial infection. Carcinogens are cancer causing agent or substance which damaged the DNA 
and promoting the cancer. For example tobacco, gamma ray. Different life style like Smoking, 
handling of toxic chemical, high fat diet is also factor for generating cancer. Some genetic 
disorder like beckwith-wiedemann syndrome and wiskott-Aldrich alter the normal immune 
system of the body and cause cancer. Cancer may also be caused by the infection of certain virus 
for example HIV and Epstein-Barr virus. HIV that causes AIDS also developing some type of 
childhood cancer.  
There are many different types of cancer. One type of cancer is breast cancer. Breast 
cancer is the most common type of cancer in females. Breast cancer generally starts from the 
inner lining of milk duct. It can also start from the lobules that supply milk. A breast cancer that 
began from lobules is known lobular carcinoma, other one which is developed from the 
lactiferous ducts is known as ductal carcinoma. Lobular carcinoma is very less common type of 
cancer but ductal carcinoma is most common type of breast cancer.  
Breast cancer (BC) is the most common type of cancer in female, every year 1 million or 
more then1 million new cases diagnosed. Current data of National cancer Institute in USA, 
232,340 female breast cancers reported per year and 2,240 male breast cancers reported per year. 
39,630 deaths reported per year. It includes both males and females. Ratio of breast cancer 
patients are very high in developed countries in comparison to small developing ones. This 
cancer is generally found in elderly aged women. Different life styles and eating habit of females 
are some of the important factors contributing to breast cancer. Though the exact causes of breast 
cancer are not known but various genetic and epigenetic changes are the ultimate focal point of 
oncogenesis in breast cancer. 
Epigenetic regulations, which regulate the expression of genes without changing its 
sequence, forms major part of etiology in breast cancer. One of the epigenetic changes is RNA 
interference. The RNA interference (RNAi) heralded a revolution in RNA biology which 
contributes significantly in regulating the expression of gene epigenetically. Small non-coding 
RNAs, eg. miRNA, siRNA, piRNA etc, comprises a greater part in RNA interference mechanism 
(Siomi and Siomi, 2009). Some of the miRNA involve in the breast cancer development. Micro 
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RNAs (miRNAs) are a class of small, ~22-nt-long endogenous, single-stranded non-coding 
RNAs (ncRNAs) that takes part in post-transcriptional gene silencing through deadenylation, 
translational repression, and destroying of their target messenger RNAs (mRNAs) (Mallick and 
Ghosh, 2012). 
The oncogenesis process is also affected by polymorphism. A great example of 
polymorphism is human ABO blood group and Rh factor. Single nucleotide polymorphisms 
(SNPs) are variation occurring in single nucleotide base on a DNA sequence. Generally 2 types 
of SNPs are present, synonymous and non-synonymous.  SNP that change the function of protein 
by changing the amino acid sequence is called as non-synonymous SNP. Synonymous SNP do 
not change the protein sequence. It is also called as silent mutation.SNP may occur in the coding 
region as well as non-coding region of a gene. These SNPs may affect whether and how 
organism develops certain disease and responds to different chemicals and drugs. SNP have great 
value in biological research and drug development and provide details of person’s susceptibility. 
(Mahdi et al., 2013) 
 
                                
                             Figure 2: Sequence showing single nucleotide polymorphism (SNP) 
 Some of the SNPs are found in miRNA or miRNA regulated gene. These can alter or 
change the miRNA binding sites. We know that miRNA modulate post-transcriptional gene 
regulation. miRNAs bind with protein coding gene (PCG) fully or partially with its 
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complementary sequence in 3’ UTR region. Sometime miRNA also bind with the coding 
sequence and 5’UTR of the mRNA. When miRNA bind with mRNA, it changes the stability and 
translation mechanism of mRNA. When SNP occurs in 3’ UTRs, it changes the mRNA stability 
and translation. It alters protein::mRNA, miRNA::mRNA interaction. SNPs present in the 
3’UTR disrupt the miRNA targeting which might contribute to cancer initiation and 
susceptibility. Based on this immense source of information, it can now be possible to uncover 
the etiological heterogeneity, clinical course, and response to treatment of different human 
cancers.  
miRNAs and single nucleotide polymorphisms associated with breast cancer have been 
collected from various literatures and online databases (dbSNP, miRBase, PhenomiR etc). 
Structural features of the 3’ UTR region of the mRNA have been studied by using different 
online tools (RNAfold, mfold etc). miRNA:mRNA interaction study has been carried out using 
customized perl scripts to find the interaction characteristics of miRNA to target 3/UTR with and 
without SNPs (nature of binding, binding energy, binding potential etc). Resulted pairs have 
been filtered and most significant pair has been selected for further validation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Review of literature 
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Review of literature: 
 
RNA has been discovered in the late 1800s, but importance of RNA in the cell is 
highlighted after DNA and protein. DNA is copied into the mRNA, then it is translated into the 
protein by the help of other two RNAs- tRNA and rRNA. In the recent years, the study of 
genome-wide approach and genome sequencing provided the details of mammalian 
transcriptome. It was revealed that mammalian transcriptome includes large number of coding 
and non-coding sequences. Coding sequence or Exon region code for protein. Non-coding RNA 
are RNA that do not code for any protein. Two types of non-coding RNAs are present, i.e. small 
non-coding RNA and long non-coding RNA. These small non-coding RNA include functionally 
important and highly abundant RNAs such as snoRNA, miRNA, piRNA, siRNA, snRNA, 
tiRNA. These RNAs are involved in many cellular processes, such as epigenetic regulation, 
transcriptional regulation, post-transcriptional regulation etc. 
Victor Ambros and colleagues discovered a gene lin-4, this lin-4 control the larval 
development in C. elegans and does not code for any protein. These lin-4 RNAs are double 
stranded and have sense and antisense strand. The antisense strand of lin-4 bind with multiple 
sites on 3’UTR of lin-14 gene. This complementary binding of lin-4 to the lin-4 gene reduces the 
lin-14 protein. This lin-4 recognized as the regulatory RNAs called as microRNA (miRNA) 
(Bartel, 2004).   
miRNA is a small, 22 nucleotide long endogenous, single stranded non-coding RNA. It 
takes part in posttranscriptional gene silencing through translational repression and 
deadenylation of their target site.  miRNAs play major role in different biological processes in 
plant and animal such as differentiation, organogenesis. tumorigenesis, cell proliferation, 
apoptosis, and  embryogenesis. The aberrant expression and deregulation of miRNA are 
implicated in risk of several diseases such as cancer. miRNA bind with 3’UTR of the mRNAs. 
Some time, it also binds with the CDS and 5’UTR. More than 30% human genes are targeted by 
the miRNAs. 
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Biogenesis of miRNA: 
 
miRNA are basically encoded in protein coding genes or intergenic regions. The 
transcription of intergenic miRNA from primary miRNA (pri-miRNA) takes place by the 
enzymatic activity of RNA polymerase III and RNA polymerase II. Intronic miRNA are co-
transcribed with their host gene. Several enzymes and proteins are involved in formation of 
miRNA. Two RNase III enzymes called Drosha and its regulatory subunit DGCR8 take part in 
cleavage of pri-miRNA transcript and generate a hairpin precursor called pre-miRNA in the 
nucleus. Pri-miRNA hairpin stem contain 33 base pairs with terminal loop and upstream and 
downstream of the hairpin.  DROSA cleave 11 base pair away from base of hairpin. This hairpin 
may be single stranded or double stranded RNA junction. Hairpin stem act as a recognition 
element for binding of DGCR8. It determines the cleavage site for Drosha processing.  Sometime 
Pri-miRNA loops also act as a binding site for nuclear ribonucleoprotein A1 (hnRNP A1). It 
change in conformation of hairpin create more favorable cleavage site for Drosha processing. 
(Mallick and Ghosh, 2012) After act of Drosha, pre-miRNA is then exported to the cytoplasm 
from nucleus by expotin-5-RanGTP. It is a nuclear transport receptor complex. Dicer acts as 
catalysis for formation multiple class of small non-coding RNA. In the mammals system, Dicer 
is aided by trans- activation responsive RNA-binding protein also called as TRBP for special 
function. In the cytoplasm dicer processed this pre-miRNA into mature 22 nt miRNA. Dicer and 
some accessory protein act on pre-miRNA and complete the process of miRNA biogenesis. 
In the next step of miRNA production, pre-miRNA is associated with Argonaute protein 
family. During the loading process, non-guided strand is cleaved by the Argonaute protein. 
Argonaute protein family play major role in gene silencing pathway. Ago protein is highly 
conserved in between species.  
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                                      Figure 3:  Step of biogenesis of miRNA  
 
 
miRNA targeting:  
 
miRNA target the mRNA and direct mRNA destabilization, and translational repression. 
So the question arise how this tinny miRNA takes part in regulation and find their target site. 
miRNA target recognition is observed from the finding on lin-4. Lin-4 had several sequences 
which is complimentary to the 3’ UTR of lin-14 mRNA (Bartel, 2009). 2-7 nucleotides of 
miRNA that bind with mRNA is called the Seed region. This binding is Watson and crick base 
pairing.  Seed region is important for miRNA target recognition.  
 
Facts/Factors of Target binding: 
 
There are several factors that determine efficient miRNA binding.  
1. miRNA bind with the 3’UTRs of the mRNA, but not bind to the two end of 3’UTR. 
2. Position of miRNA binding in 3’UTR should at least 15 nt away from the stop codon. 
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3. Position should away from the center of long UTR. 
4. If one miRNA bind multiple site so this miRNA will have great effect in regulation. 
5. A-U rich nt composition near the target site. 
6. Structure of mRNA should be feasible their for binding of the miRNA. 
 
Types of target site: 
 
1. Canonical site. 
2. Marginal site. 
3. Atypical site. 
 
Canonical site- It is most traditional and well know site for miRNA binding. Three type of 
canonical site is present, 
• 7 mer-A1 site 
• 7 mer-M8 
• 8 mer 
 
7mer-A1 site binding will be from 2-7 nucleotides from the 5/ end of miRNA and “A” 
will be in target mRNA corresponding to first position of miRNA. In 7mer-m8, binding from 2 
to 8th position of miRNA occurs. In 8mer, 2-8 base pairing is present plus “A” on the target 
mRNA corresponding to first position of miRNA. Second type is marginal site consisting of two 
type of sites- one is 6 mer (2-7 base pairing) and another is offset 6 mer (3-8 base pairing). 
 
Third is Atypical site. It also contains two types: 
1. 3’Supplementary site 
2. 3’compensatory pairing. 
 
By certain experimental evidence proved that 3’supplementary pairing increase the binding 
specificity and affinity of seed pairing. 3’ supplementary pairing is productive and associated 
with different sufficient number of sites. Beside the conventional seed region complementarily 
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additional base pairing has been found at 12-17 nt position of mRNA know as 3’ supplementary 
site. Compensatory site, Watson-crick pairing usually centering on miRNA nucleotide 13-16 can 
compensate for seed mismatch and thereby create a functional site. If a seed region has some of 
the wobbles pairing the  pairing compensate by the compensatory pairing.  Although miRNA has 
diverse binding sites but 8mer binding site has been found to be most efficient one for successful 
target degradation.  
 
                                     
 
                   
Figure 4: Different type of target site (Bartel, 2009) 
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Polymorphism defined as a different form of an allele in a gene. It defines as morphs of the 
phenotype. More than 1% genetic variation in a population called as Single nucleotide 
polymorphism . The SNP is common single nucleotide variation in the human genome. It is a 
type of mutation in an individual, but the percentage of the mutation rate is high. SNP arises 
because of point mutation. The SNP may present in the coding region, non-coding region or 
intergenic regions. Most of SNP occur in non-coding region.(Gray et al., 2000) 
 
There are two types of base substitution resulting in SNPs 
• Transition substitution- In this substitution change in nucleotide happen in between 
purines to purines and pyrimidines to pyrimidines. 
• Transversion substitution- change of nucleotide occurs in between purine and 
pyrimidines. 
 
 
 
                                          Figure 5:  Two types of base substitution  
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Distribution of SNPs 
 
SNP presents in entire human genome. SNP rate is very lower in sex chromosome. Most 
of the SNP is present in the coding region. 
 
Synonymous: Addition on deletion of nucleotide not change the amino acid, so no change in the 
protein. It is also called as silent mutation. 
 
Non- Synonymous: Addition on deletion of nucleotide changes the amino acid. It is missense 
mutation. It changes the protein. Most of the SNP result in non-synonymous codon changes.  
 
Importance of SNPs: 
 
• It is used to find the genetic similarity and dissimilarity among the population. 
• Finding the disease gene. 
• SNP detection explains and diagnoses many diseases. 
• Study variation in drug responses. 
Role of SNPs in cancer: 
Genetic variation has silent, harmful & harmless effects. By the help of “SNP” now people can 
observe different level of individual cancer risk. This type of variation found in the coding 
region. SNP changes the amino acid and because of changes in one amino acid 3D structure of 
protein is changed. This protein changes the metabolism of the body and makes the person 
susceptible to cancer. This protein converts the procarcinogen into the carcinogen. In a normal 
person this protein is absent, but the person has SNP in their gene produced protein, which 
convert the procarcinogen substance to carcinogen substance very actively. 
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                                                    Figure 6: SNP and cancer risk. 
 
SNP regulates the miRNA targeting is also one of the causes of different cancers. 
miRNAs have fundamental importance in growth control, differentiation and human disease such 
as cancer. miRNAs bind with the 3’ UTR of mRNA. SNP affects the miRNAs binding. If the 
SNP present in a miRNA target site, then it implicated in several diseases. By the recent 
annotation study of SNP and miRNA gene give the detail of change of miRNA targeting because 
of SNP. (Stahlhut Espinosa and Slack, 2006). SNP present in seed region it alter the miRNA-
mRNA targeting. A SNP can change, create and modified the miRNAs targeting site. This 
change decrease or increase the protein translation mechanism. When SNP present in 3’ UTR 
gene it implicated in many cancer and enhanced the tumorogenisity. SNP effects on miRNAs 
targeting according to the difference in binding free energy and alignment scores. 3’UTR are 
likely to be downregulated by particular miRNA. (Xu et al., 2013). 
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SNP increases the breast cancer risk in female. Mutation in these genes such as ATM, 
BARD 1,  PMS1, BARCA1,  BARCA2, BRIP1, CDH1, APE1 increase the breast cancer. For 
example, the human DNA repair system prevents the DNA damage caused by certain 
environmental agent. AP endonuclease 1 (APE1) is one of the protein, which take part in the 
DNA repair mechanism. It acts as 3’-phosphodiesterase and repair DNA single strand breaks. It 
directly removes the damaged bases by enzyme action. It is a promising tool used for anticancer 
therapy. Polymorphism in DNA repair gene influence the susceptibility to carcinomas. 
Polymorphism in APE1 was associated with the several cancer risks. In human genome is APE1 
located on chromosome 14q11.2-q12 and encodes a 317 amino acid protein. Several sequence 
variation present in this gene changes the amino acid from aspartic acid to glutamic acid( SNP 
id- rs3136820). Meta-analysis suggested that the APE 1 rs3136820 polymorphism was a major 
risk factor for breast cancer  (Zhao et al., 2014). PPMID gene also involve in increase risk of 
breast cancer. If the women with PPMID gene mutation then she have 20% chance to developing 
breast cancer.(Mahdi et al., 2013).   5-10% of breast cancer are thought to be hereditary. That is 
caused by the abnormal gene.  Some of the gene such as breast cancer susceptibility gene 
1(BRCA1) and breast cancer susceptibility gene 2 (BRCA 2) are hereditary gene associated with 
breast cancer. Mutation in BRCA1 and BRCA2 gene in germline cell cause susceptibility to 
breast cancer. If the high frequency of mutation showed in gene so the gene product is changed. 
If a female carries mutated BRCA1 and BRCA2 gene, then she has high risk to develop breast 
cancer during lifetime. Checkpoint kinase2 (CHEK2) encode a G2 checkpoint kinase. It is 
involved in DNA damage repair. CHEK2 1100delC gene mutation increases the breast cancer.   
 
SNP rs-13281615 located in the 8q24 chromosomal region involved in the development 
of many types of cancer including breast cancer. This SNP location is nearby myelocytomatosis 
oncogene (MYC) which promotes diffensiation , cell proliferation and transformation. Variation 
in gene alter the c-MYC expression and increased breast cancer susceptibility.(Gong et al., 2013)  
SNP in the miR367 binding site at the 3’UTR of the RYR3 gene affects the breast cancer risk. 
RYR3 is third isoform of the RYR family. It is calcium induced calcium release channel protein 
and controls the cytoplasm calcium level.  RYR is commonly expressed in breast cancer. It is a 
14 | P a g e  
 
biomarker for identify breast cancer prognosis and oncogenic mutation.  RYR3 plays a role in 
breast calcification. By Bioinformatics prediction provides the detail of SNP present in 3’UTR of 
RYR3 gene and associated with cancer risk. RYR3 gene is the principal regulator of breast 
cancer cell growth. Genetic variation in the RYR3 gene affects the intracellular calcium influx 
and cell proliferation as well. (Zhang et al., 2011). 
Epistasis or gene-gene  interaction has also contributed to increased breast cancer risk.  
Sometime singe SNP not able to Cause Breast cancer. SNP-SNP interaction is contributed to 
influencing breast cancer risk. (Onay et al., 2006).   
 
For study of miRNA –SNP interaction various data is collected from different database. 
(Nicoloso et al., 2010). The human miRNA sequence is collected from miRbase and SNP 
collected from the NCBI site. Interact the collected sequence by use of Bioinformatics tool. Find 
those pairs which are energetically efficient and calculate the minimum free energy of this 
pairing. Find the energetically relevant pair. By several interactions studies, we conclude that the 
BC susceptibility increased because of the SNP mediated change, create and modified of miRNA 
targeting. 
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OBJECTIVES: 
 
OBJECTIVE 1 
 
Data retrieval: Collection of SNPs and miRNAs  involved in breast cancer.  
 
 
OBJECTIVE  2 
 
Target prediction: Study of interaction between SNPs and miRNAs  
 
 
OBJECTIVE 3 
 
Identification of significant pairs of target SNPs-miRNAs 
 
 
 
  
 
 
 
 
  
 
 
 
 
 
 
 
 
Materials and Methods 
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Materials and methods: 
 
DATA retrieval:  
  
Collection of SNP: Extensive literature studies have been carried out to find the single 
nucleotide polymorphisms reported to be associated with breast cancer from. SNPs present in 
different genic regions, ex. 3’UTR, 5’UTR, intron, CDS, others, have been retrieved. The 
sequence informations of the SNPs have been retrieved from dbSNP database. 
miRNA data mining: Differentially expressed microRNAs in breast cancer system have been 
retrieved from various published literatures and online databases (ex. PhenomiR, OncomiR). Up 
regulated microRNas were taken for the interaction study. The sequence informations of the 
miRNAs have been retrieved from miRBase database. 
 
Target prediction: 
1. We have collected the ancestral and mutated SNP sequences in breast cancer system from 
dbSNP. The text file was splitted into three files separating ancestral sequence, mutated 
sequence and variation using customized pearl script.  
2. The upregulated miRNAs in breast cancer obtained from various databases were 
considered for the miRNA:SNP interaction study for both the cases i.e., ancestral and 
mutated SNP dataset using RNAhybrid. The criteria set for the above interaction study 
are as follow. 
a) 8mer binding sites with binding energy < -1 kcal/mol 
b) 7mer binding sites with binding energy < -1 kcal/mol 
c) Off-set 6mer binding sites with binding energy < -1 kcal/mol 
d) Interactions with binding energy < -10 kcal/mol 
3. For both the cases the above interaction files were merged into a single file and further 
filtration to find best interaction was carried out using customized pearl scripts basing on 
the binding pattern and binding energy.    
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4. R statistical package was used to sort the miRNA:SNP pair on the basis of  percentage 
minimum free energy change between miRNA interaction with the ancestral and mutated  
sequences.  
5. Finally, five interactions, which were significantly affecting breast cancer etiology have 
been filtered and the pairs were taken for further validation studies showing significant 
differences in binding pattern and binding energy. 
Structural Analysis: 
Structural analysis of the folded  mRNA has been carried out to check the site availability for 
binding of miRNA  and to compare the site morphology due to presence and absence of SNP. 
  The sequence of the mRNA was retieved and taken for folding study. 
 The sequence was folded using different online tools (ex, RNAfold, mfold). 
Cell culture: 
Cell culture is a process by which a cell grows under the control condition outside of the 
natural environment by proving media and certain growth  regulator. MDA-MB-231 is human 
breast carcinoma cell line which was obtained from national center for cell science (NCCS), 
Pune. DMEM media  with 10% FBS (Fetal bovine serum) was used for culturing the cell. 
NuncTM  cell culture flask is used. The cell culture flask contain breast cancer cell line kept in 
CO2 incubator. CO2 level is maintained at 5%. Medium contained phenol red it defines the pH 
level in the medium. The incubator temperature set at 370C for maintaining the physiological 
temperature in the cell culture environment. 
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Steps of cell culture: 
1. Cell Harvesting: 1x 107 cells were grown in suspension. Cells were pelleted down by 
centrifugation for 5 min at 300 x g. Suparnateant was removed carefully. Direct lysis in 
the vessel at the appropriate volume of buffer RLT. 
2. Tryprinization of cell: Medium is removed and cell was washed with phosphate buffer 
saline (PBS). Then PBS is removed and 0.1-0.25% trypsin was added. Kept for 2-3 min. 
The cell was detached from the flask surface. After this cell culture medium was added. 
No need to remove trypsin from the cell. A medium containing the serum to inactive the 
trypisin. In next step cell was transferred to an RNase-free glass or polypropylene 
centrifuge tube and centrifuged at 300x g for 5 min. Supernantent was removed carefully. 
Cells are resuspend in fresh media and put in incubator.  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Results and Discussions 
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Results and discussions: 
 
Extensie literature studies have been carried out to single nucleotide polymorphisms 
reported to be present in different genic regions, ex. 3’UTR, 5’UTR, Exon, Intron, CDS etc. In 
breast cancer, 59 SNPs were reported in 3’ UTR, 9 SNPs were reported in 5’ UTR, 119 SNPs 
were reported in CDS, 242 SNPs were reported in Introns,175 SNPs were reported in other 
regions. 
 
 
                                      
   
              Figure 7: Distribution of SNP in different region of breast cancer associated gene  
 
 
MicroRNAs that are differentially expressed in breast cancer have been retrieved from 
different published literatures and online databases(Ex miRBase, PhenomiR, miRCancer etc). 75 
miRNAs were found to be upregulated in breast cancer system. 
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Table 1.  Name of 76 upregulated miRNAs reported in breast cancer. 
hsa‐let‐7d*  hsa‐miR‐30c‐1*  hsa‐miR‐3197  hsa‐miR‐601 
hsa‐miR‐1180  hsa‐miR‐30c‐2*  hsa‐miR‐3198  hsa‐miR‐610 
hsa‐miR‐1207‐5p  hsa‐miR‐3125  hsa‐miR‐32*  hsa‐miR‐617 
hsa‐miR‐1228*  hsa‐miR‐3131  hsa‐miR‐3202  hsa‐miR‐622 
hsa‐miR‐1237  hsa‐miR‐3138  hsa‐miR‐320c  hsa‐miR‐630 
hsa‐miR‐1254  hsa‐miR‐3141  hsa‐miR‐3614‐5p  hsa‐miR‐642b 
hsa‐miR‐1268  hsa‐miR‐3148  hsa‐miR‐3667‐5p  hsa‐miR‐659 
hsa‐miR‐1275  hsa‐miR‐3149  hsa‐miR‐3676  hsa‐miR‐670 
hsa‐miR‐129‐5p  hsa‐miR‐3161  hsa‐miR‐3679‐3p  hsa‐miR‐708 
hsa‐miR‐1305  hsa‐miR‐3180‐3p  hsa‐miR‐3679‐5p  hsa‐miR‐711 
hsa‐miR‐1306  hsa‐miR‐3185  hsa‐miR‐373*  hsa‐miR‐765 
hsa‐miR‐139‐3p  hsa‐miR‐3187  hsa‐miR‐3945  hsa‐miR‐877 
hsa‐miR‐151‐3p  hsa‐miR‐3189  hsa‐miR‐422a  hsa‐miR‐892b 
hsa‐miR‐187*  hsa‐miR‐3190  hsa‐miR‐4274  hsa‐miR‐595 
hsa‐miR‐188‐5p  hsa‐miR‐3195  hsa‐miR‐4294  hsa‐miR‐33b* 
hsa‐miR‐18b*  hsa‐miR‐3197  hsa‐miR‐483‐5p  hsa‐miR‐30b* 
hsa‐miR‐1909*  hsa‐miR‐3198  hsa‐miR‐500a   
hsa‐miR‐202  hsa‐miR‐32*  hsa‐miR‐501‐5p   
hsa‐miR‐206  hsa‐miR‐3202  hsa‐miR‐520b   
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hsa‐miR‐21*  hsa‐miR‐320c  hsa‐miR‐520e   
hsa‐miR‐2278  hsa‐miR‐331‐3p  hsa‐miR‐550a   
hsa‐miR‐23a*  hsa‐miR‐338‐5p  hsa‐miR‐583   
 
We interacted the different  upregulated miRNA   and SNP  reported in breast cancer by in-
silico method. By target prediction  we found 34 miRNA:SNP pairs. The obtained pairs are 
further filtered and finally pairs having a more significant association  were screened.  Siginicant 
pair was filtered on the basis of : 
1. Number of G-U pairing present. Maximum permissible G-U pairing should  be 2. 
2. Maximum free energy should be > +20 and< - 20. 
On the basis of these three criteria we found six significant pairs. Then the whole 3’ UTR 
region of the finally screened genes were folded in different online RNA folding tools, ex :RNA 
fold, Mfold, Sfold etc., to predict the availability of the target site for the micro RNA action. 
There was significant difference in site availability between ancestral and mutated form of the 3’ 
UTR region of the gene. The screened pairs were taken for the further study.  
Table 2. List of SNP:miRNA  pair involved in breast cancer 
SNP ID and 
gene name 
miRNA  miRNA 
binding Site in 
ancestral  
miRNA target 
change in 
mutated  
 Mutation Energy 
variation. 
rs1259938 
(MBD2) 
hsa-miR-1254 8mer Other A/G -27.34 
rs3734805 
(CCDC170) 
hsa-miR-483-
5p 
Other 7mer-m8 A/C -24.21 
rs7441 (DNC) hsa-miR-4835p Other 8mer C/T -21 
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rs11662595 
(HRH4) 
hsa-miR 3138 Other 7mer-A1 A/G -20 
rs7539542 
(ADIPOR1) 
hsa-miR-3180-
3p 
7mer-m8 6mer C/G -27.35 
Rs74441 
(DCN) 
hsa-miR-4360 Other 7mer-A1 C/T -41.81 
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Conclusions: 
From extensive literature studies, we have collected a total of 604 SNPs present in different 
genic regions which are significantly associated with breast cancer. We also collected 197 
differentially expressed miRNAs in breast cancer from various databases. From the RNAHybrid 
analysis, we have filtered six SNP:miRNA pairs which clearly depicts the significant changes in 
target sites leading to alteration in miRNA targeting. For example, DCN gene coding for Decorin 
protein influence fibrillogenesis, inhibit the activity of TGF-beta1,  inhibit cell proliferation, 
collagen systhesis, DNA synthesis. The presence of the SNP in DCN gene changes the miRNA 
targeting and a new target site is created. This creation of a new miRNA target site due to 
presence of SNP might be contributing to the downregulation of DCN and might be influencing 
Breast cancer sustcepitibility. Form the above interaction studies, we can hypothesize that 
occurance of SNPs in the target site of miRNA can modulate the mode of regulation of mRNA 
by the corresponding miRNA which ultimately might be involved in breast cancer.  
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